India to Germany: Loperamide Export Trade Route
India has recorded 71 verified shipments of Loperamide exported to Germany, representing a combined trade value of $827.9K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $11.7K USD. The leading Indian exporter is TENSHI KAIZEN PRIVATE LIMITED, which accounts for 54% of total export value with 33 shipments worth $443.6K USD. On the buying side, KLINGE PHARMA GMBH is the largest importer in Germany with $391.7K USD in purchases. The top 3 suppliers — TENSHI KAIZEN PRIVATE LIMITED, TORRENT PHARMACEUTICALS LTD, TENSHI KAIZEN PRIVATE LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Germany Loperamide corridor is one of India's established pharmaceutical export routes, with 71 shipments documented worth a combined $827.9K USD. The route is dominated by TENSHI KAIZEN PRIVATE LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's loperamide manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $11.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 29.9%, placing it at rank #9 among India's top loperamide export destinations globally.
On the import side, key buyers of Indian loperamide in Germany include KLINGE PHARMA GMBH, HEUMANN PHARMA GMBH CO GENERICA KG, HEUMANN PHARMA GMBH CO.GENERICA KG and 12 others. KLINGE PHARMA GMBH is the single largest importer with 31 shipments valued at $391.7K USD.
